Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2025-07-11 00:00:00 ET · period of report 2025-07-09 · accession 0001439222-25-000082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-07-11 | 2025-07-09 | AGIO | Gheuens Sarah | Chief Medical Off | S - Sale+OE | $37.99 | -11.9K | 62.1K | -16% | -$452.6K |
| D | 2025-07-11 | 2025-07-09 | AGIO | Gheuens Sarah | Chief Medical Off | M - OptEx | $25.01 | +11.9K | 73.2K | +19% | +$298.0K |
| D | 2025-07-11 | 2025-07-09 | AGIO | Gheuens Sarah | Chief Medical Off | M - OptEx | $0.00 | -11.9K | 32.1K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2025-07-09 | S | D | 847 | $38.76 | 61,271 | D | — | — | (F3) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $38.55 to $38.87. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common stock | 2025-07-09 | S | D | 11,067 | $37.93 | 62,118 | D | — | — | (F2) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $37.52 to $38.49. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common stock | 2025-07-09 | M | A | 11,914 | $25.01 | 73,185 | D | — | — | |
| 4 | Derivative | Stock options (right to buy) | 2025-07-09 | M | D | 11,914 | $0.00 | 32,086 | D | $25.01 · — to 2033-03-01 | 11,914 Common stock | (F4) This option was originally granted on March 1, 2023 for the purchase of 44,000 shares of common stock. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter. |